Zydus gets USFDA nod for doxycycline tablets
Zydus Cadila has received final approval from the US health regulator to market doxycycline tablets, used for the treatment of different types of bacterial infections such as acne and eye infection.
Zydus Pharma recalls 44,800 bottles of antidepressant in US
Cadila Healthcare's US arm, Zydus Pharmaceuticals USA Inc, is recalling 44,800 bottles of antidepressant Paroxetine tablets from the American market Zydus settles patent case over Aptalis' drug Canasa
Zydus group firm Cadila Healthcare today said patent litigation relating to Aptalis' drug Canasa used for treatment of ulcerative colitis has been settled. As a result of the settlement, the... Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Zydus Wellness Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here Outcome of AGM
Announcement of the Consolidated results of e-voting and poll conducted at the twenty third annual general meeting of Zydus Wellness Limited held on August 11, 2017 Outcome of AGM
Proceedings of 23rd AGM of the members of Zydus Healthcare Limited held on Friday, August 11, 2017 Scrutinizer's Report
Scrutinizer's consolidated on remote evoting conducted pursuant to section 108 of the Companies Act 2013 read with rule 20 of the Companies [Management and Administration] Rules, 2014 and voting on Poll at 23rd AGM of Zydus Wellness Limited held on Friday, August 11, 2017 Post Results [Q1 2017-2018 April - June 2017] Q&A; Session Through Teleconference Has Been Scheduled On August 10, 2017, Thursday At 5:30 P.M.
As per the attached letter.